Deprescribing guidelines with algorithms and other implementation tools
Evidence-based, easy-to-use algorithms for deprescribing commonly use medications: includes links to full publications, and tools such as: algorithms, whiteboard videos and patient infographics and pamphlets. Led by Dr. Barbara Farrell’s research team at the Bruyere Research Institute in Canada, including in partnership with Dr. Emily Reeve, University of Sydney.
Cholinesterase Inhibitors (ChEIs) and Memantine. Evidence-based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine.
Visit deprescribing.org for guidelines and other resources for:
- Proton Pump Inhibitors
- Benzodiazepine Receptor Antagonist
Deprescribing guides for use in hospital
Guidance for clinicians to support decisions on whether and how to deprescribe specific drug classes. Complementary resources for clinicians to give consumers to support implementation of deprescribing decisions. The deprescribing resources have been developed by a translational research project team led by Prof Sarah Hilmer, for clinicians to support deprescribing in older hospital patients.
Primary Health Tasmania deprescribing guides
Primary Health Tasmania has deprescribing guides for medications, deprescribing fact sheets videos and other resources for consumers and healthcare professionals. Primary Health Tasmania is an organisation under the Australian Government’s Primary Health Networks Program. Their deprescribing resources have been created and revised by the Deprescribing Reference Group, geriatrician Dr David Dunbabin, GP Dr Amanda Lo and pharmacist Dr Peter Tenni.